Coriell Life Sciences, Inc. — Form D
Coriell Life Sciences, Inc. of PHILADELPHIA, PA, a company, filed a Form D exempt-offering notice with the SEC on 2019-05-06. The offering totals $10.0M, of which $9.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2019-05-06
- Form: D
- Accession: 0001675480-19-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $10.0M
- Amount sold: $9.5M
- Remaining: $550K
- Investors: 4
- Date of first sale: 2019-04-26
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-338841
Issuer
- Name: Coriell Life Sciences, Inc.
- CIK: 0001675480
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 4747 SOUTH BROAD STREET, PHILADELPHIA, PA, 19112
- Phone: 888.415.7834
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Dr. Stephen Andriole | Director | Philadelphia, PA |
| Peter Driscoll | Director | Philadelphia, PA |
| Scott Megill | Director | Philadelphia, PA |
| Scott Megill | Executive Officer | Philadelphia, PA |
| Stephen F Andriole | Director | Camden, NJ |
| Michael F Christman | Director | Camden, NJ |
Other filings by this issuer (1)
More